Literature DB >> 4212423

The influence of stereochemical factors on drug disposition.

P Jenner, B Testa.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4212423     DOI: 10.3109/03602537409030008

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  16 in total

Review 1.  Stereoselectivity in clinical pharmacokinetics and drug development.

Authors:  D B Campbell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

Review 2.  Stereoselectivity in pharmacokinetics: a general theory.

Authors:  R H Levy; A V Boddy
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

Review 3.  Enantiomeric resolution of drug compounds by liquid chromatography.

Authors:  H T Karnes; M A Sarkar
Journal:  Pharm Res       Date:  1987-08       Impact factor: 4.200

4.  Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based (LARIHC) and cyclobond I 2000 RSP HPLC chiral stationary phases.

Authors:  Nilusha L T Padivitage; Edra Dodbiba; Zachary S Breitbach; Daniel W Armstrong
Journal:  Drug Test Anal       Date:  2013-09-20       Impact factor: 3.345

5.  Population pharmacokinetics of oral baclofen in pediatric patients with cerebral palsy.

Authors:  Yang He; Janice E Brunstrom-Hernandez; Liu Lin Thio; Shellie Lackey; Deborah Gaebler-Spira; Maxine M Kuroda; Elaine Stashinko; Alexander H Hoon; Jilda Vargus-Adams; Richard D Stevenson; Stephanie Lowenhaupt; John F McLaughlin; Ana Christensen; Nienke P Dosa; Maureen Butler; Aloysia Schwabe; Christina Lopez; Desiree Roge; Diane Kennedy; Ann Tilton; Linda E Krach; Andrew Lewandowski; Hongying Dai; Andrea Gaedigk; J Steven Leeder; William J Jusko
Journal:  J Pediatr       Date:  2014-03-05       Impact factor: 4.406

Review 6.  Importance of drug enantiomers in clinical pharmacology.

Authors:  K Williams; E Lee
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

7.  Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology.

Authors:  E J Ariëns
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  The importance of stereochemistry in the clinical pharmacokinetics of the 2-arylpropionic acid non-steroidal anti-inflammatory drugs.

Authors:  A J Hutt; J Caldwell
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

9.  The metabolism of [14C]-debrisoquine in man.

Authors:  J R Idle; A Mahgoub; M M Angelo; L G Dring; R Lancaster; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

10.  Metabolism of anti-herpes agent 5-(2-chloroethyl)-2'-deoxyuridine in mice and rats.

Authors:  I Szinai; Z Veres; K Ganzler; J Hegedus-Vajda; E De Clercq
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Apr-Jun       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.